Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
J. Keith Joung
AddedMar 31, 2024
UpdatedMay 31, 2026
J. Keith Joung

J. Keith Joung

Co-Founder, Verve Therapeutics

CrunchbaseLinkedIn

J. Keith Joung's Career

Verve Therapeutics
Verve Therapeutics

Boston, MA, US

Co-Founder
Beam Therapeutics
Beam Therapeutics

Cambridge, MA, US

Co-Founder
Editas Medicine
Editas Medicine

Cambridge, MA, US

Board Member· Board
Beam
Beam

Seattle, WA, US

Co-Founder
SeQure Dx
SeQure Dx

Waltham, MA, US

Co-Founder
Pairwise Plants
Pairwise Plants

Durham, NC, US

Co-Founder
Chroma Medicine
Chroma Medicine

Cambridge, MA, US

Co-Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

J. Keith Joung's Career

Verve Therapeutics
Verve Therapeutics
Public$419.3M2042018Boston, MA, US
Co-Founder

Leadership at Verve Therapeutics

Sekar KathiresanSekar KathiresanCo-Founder
Anthony PhilippakisAnthony PhilippakisBoard Member
Krishna YeshwantKrishna YeshwantBoard Member
Issi RozenIssi RozenCo-Founder
Barry TichoBarry TichoCo-Founder
Bo CumboBo CumboBoard Member
Beam Therapeutics
Beam Therapeutics
Public$689M5072017Cambridge, MA, US
Co-Founder

Leadership at Beam Therapeutics

Graham CooperGraham CooperBoard Member
John EvansJohn EvansBoard Member
Feng ZhangFeng ZhangCo-Founder
John EvansJohn EvansCEO
Carole HoCarole HoBoard Member
Robert NelsenRobert NelsenBoard Member
Editas Medicine
Editas Medicine
Public$931.6M2262013Cambridge, MA, US
Board Member· Board

Leadership at Editas Medicine

Akshay VaishnawAkshay VaishnawBoard Member
Gilmore O’NeillGilmore O’NeillBoard Member
Meeta ChatterjeeMeeta ChatterjeeBoard Member
George ChurchGeorge ChurchBoard Member
Andrew HirschAndrew HirschBoard Member
Emma ReeveEmma ReeveBoard Member
Beam
Beam
Seed$6.7M42021Seattle, WA, US
Co-Founder

Leadership at Beam

Luke LombardiLuke LombardiFounder
Eli MernitEli MernitFounder
Feng ZhangFeng ZhangCo-Founder
David R. LiuDavid R. LiuCo-Founder
John EvansJohn EvansBoard Member
SeQure Dx
SeQure Dx
Series A$17.5M292020Waltham, MA, US
Co-Founder

Leadership at SeQure Dx

Ellen SheetsEllen SheetsCo-Founder

Similar to SeQure Dx

DxNADxNASt. George, UT, USDiagnostic Testsest. 2005DxNASt. George, UT, US · est. 2005

DxNA LLC, a Utah-based medical organization, develops affordable, rapid molecular diagnostic tools, focusing on infectious diseases for underserved hospitals and clinics.

Angel · $6.6M19
Smart Diagnostics SystemsSmart Diagnostics SystemsJefferson City, MO, USDiagnostic Platformsest. 2016Smart Diagnostics SystemsJefferson City, MO, US · est. 2016

Smart Dxs designs and distributes advanced diagnostic technologies for disease prevention in various industries.

Seed · $120k5
Empowered DiagnosticsEmpowered DiagnosticsPompano Beach, FL, USDiagnostic Testsest. 2017Empowered DiagnosticsPompano Beach, FL, US · est. 2017

Empowered Diagnostics: Reliable, affordable, high-quality diagnostic tests for informed health decisions.

Seed · $4.7M13
Predictive Health Diagnostics CompanyPredictive Health Diagnostics CompanyIrvine, CA, USDiagnostic Testsest. 2017Predictive Health Diagnostics CompanyIrvine, CA, US · est. 2017

Predictive Health Diagnostics: Transforming data into intelligent, science-driven diagnostic tests.

Series A · $17.3M29
Pairwise Plants
Pairwise Plants
Series B$115M752017Durham, NC, US
Co-Founder

Recent news

Sequoia nears first Asia-Pacific deal since regional splitTechCrunch · 2024

Leadership at Pairwise Plants

Tom AdamsTom AdamsCEO
Michelle GloecklerMichelle GloecklerBoard Member
Kiersten SteadKiersten SteadCo-Founder

Similar to Pairwise Plants

Plant Pathways CompanyPlant Pathways CompanySt. Louis Park, MN, USPlant Varieties, Steviaest. 2019Plant Pathways CompanySt. Louis Park, MN, US · est. 2019

Plant Pathways Co.: Innovating health-focused food and medicinal plant varieties.

Series A · $4M30
Inari AgricultureInari AgricultureCambridge, MA, USPlant Varietiesest. 2016Inari AgricultureCambridge, MA, US · est. 2016

Inari, founded in 2016, uses predictive design to create high-performing plant varieties for sustainable agriculture.

Series F · $609M465
PlastomicsPlastomicsSt. Louis, MO, USCrop Enhancementest. 2017PlastomicsSt. Louis, MO, US · est. 2017

Plastomics Inc., a US biotech startup, enhances crop performance through chloroplast genetic engineering.

Series A · $9.4M29
BayspairBayspairMountain View, CA, USGenome Editingest. 2022BayspairMountain View, CA, US · est. 2022

Bayspair Inc.: A leading biotech startup specializing in flexible genome editing for agriculture and therapeutics.

Seed · $3.5M5
Chroma Medicine
Chroma Medicine
Series B$260M1372021Cambridge, MA, US
Co-Founder

Leadership at Chroma Medicine

Catherine Stehman-BreenCatherine Stehman-BreenCEO
Kevin BittermanKevin BittermanBoard Member
Jonathan WeissmanJonathan WeissmanCo-Founder

J. Keith Joung's Similar Executives & Operators

Nugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiBo ZhangBo ZhangCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance Retail

People Similar to J. Keith Joung

Edgar G. EnglemanEdgar G. EnglemanFounder · Biotechnology Development Fund VINathaniel DavidNathaniel DavidBoard Member · Unity BiotechnologyPhillip D. ZamorePhillip D. ZamoreBoard Member · Voyager TherapeuticsJoel DudleyJoel DudleyBoard Member · Harmonic DiscoveryBrian D. AtheyBrian D. AtheyCo-Founder · Phenomics HealthCarlos BustamanteCarlos BustamanteCo-Founder · Arc Bio